Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trafficking protein, kinesin binding 2 pseudogene (LOC100421116, ENSG00000271419) is classified as a pseudogene of the TRAK2 gene, which encodes a kinesin-binding protein involved in intracellular trafficking, especially mitochondrial and endosomal transport. However, as a pseudogene, LOC100421116 does not encode a functional protein and is generally considered a non-coding genomic element, although some pseudogenes may contribute to regulatory RNA functions or gene expression modulation[3][5][6]. There is no established role as a drug target, nor are there known interacting drugs, biomarkers, or specific disease associations directly attributable to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking protein, kinesin binding 2 pseudogene.